P4O: Planning for Outcomes P4O is intended to help policy makers, family planning and HIV program planners, and other stakeholders understand the potential impact of a change in injectable contraceptive prevalence on pregnancy and HIV outcomes. ...
Website: The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study The ECHO Study compares three reversible methods of contraception, the progestogen-only contraceptive depot medroxyprogesterone acetate (DMPA), the Jadelle sub-dermal implant and the copper...
FP2020 Integrating Family Planning and HIV Women of reproductive age are disproportionately affected by the HIV/AIDS epidemic. Many women are simultaneously at risk for both unintended pregnancy and HIV infection. Comprehensive reproductive health care that includes...
ECHO Study Fact Sheet The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label randomised clinical trial comparing three highly effective, reversible methods of contraception — a progestogen-only injectable called depot-medroxyprogesterone...
Recent Comments